Laparoscopic Renal Cryoablation (LRC) Of Small Renal Masses UroToday.com - A group from Milan, Italy prospectively analyzed the outcome of patients with kidney masses treated with laparoscopic cryoablation over a 7-year period. Beginning in September 2000, 104 patients (mean age 61.6 years; 78 male and 26 female) underwent LRC for renal masses. The mean lesion diameter was 2.2cm.
Source: www.medicalnewstoday.comA Large Open Label, Non-Comparative, Phase III Study Of The Multi-Targeted Kinase Inhibitor Sorafenib In European Patients UroToday.com - Dr. Verzoni presented a trial to collect safety and efficacy data on sorafenib from a large and broad study population reflecting clinical practice. This nonrandomized, open-label study included male and female patients, aged ≥18, with an ECOG PS 0 2 and a life expectancy 2 months. Patients had to be unsuitable for or have failed prior cytokine therapy.
Source: www.medicalnewstoday.comComputational Quantum Chemical Methods Promising For Drug Development Research, led by a Virginia Tech chemist, may someday help natural-products chemists decrease by years the time it takes to develop certain types of medicinal
drugs. The research by T.
Source: www.medicalnewstoday.comCaution Advised When Using Hormone Therapy For Prostate Cancer In men with localized but aggressive prostate cancer, the combination of testosterone-lowering therapy and radiation improves survival substantially more than radiation therapy alone. But testosterone-lowering therapy isn't so hot for the heart, reports the April issue of the Harvard Heart Letter. Low testosterone can increase harmful LDL cholesterol, blood sugar, blood pressure, and weight.
Source: www.medicalnewstoday.comAmgen's Oncology Pipeline Data Highlighted At Upcoming Scientific Meeting Amgen (NASDAQ: AMGN) announced that results from several preclinical and clinical trials investigating cancer treatment will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2008 in San Diego between April 12-16, 2008. Data will be presented on pipeline compounds: AMG 102, AMG 386, AMG 479, AMG 655 and motesanib diphosphate (AMG 706).
Source: www.medicalnewstoday.comManagement Of Superficial Bladder Tumors UroToday.com - This presentation addressed the issue that recurrence at first follow-up cystoscopy (RR-FFC) after TURBT has been attributed to incomplete resection of the tumor. Furthermore, an EORTC analysis of multicenter trials suggested the inter-institutional variability of RR-FFC was a result of variable TURBT 'quality'. Dr.
Source: www.medicalnewstoday.comFDA Approves Rotarix [Rotavirus Vaccine, Live, Oral], The First Vaccine Licensed To Complete The Rotavirus Immunisation Series By Four Months Of Age GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Rotarix� [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants. Rotarix will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age. The U.S.
Source: www.medicalnewstoday.comRadical Nephrectomy Is Not Superior To Nephron-Sparing Surgery In PT1b-pT2N0M0 Renal Tumors UroToday.com - Dr. Patard from Rennes, France presented on behalf of a large international group regarding partial nephrectomy (PN) and radical nephrectomy (RN) in the setting of organ confined tumor measuring more than 4 cm.
Source: www.medicalnewstoday.comScarless Nephrectomy By Transgastric And Transvesical Combined Approach UroToday.com - Dr. Lima from Porto, Portugal presented the novel concept of "natural orifices translumenal endoscopic surgery" (NOTES) as applied to nephrectomy in an experimental model. Their team assessed the feasibility of a combined transgastric and transvesical approach for performing nephrectomy in a porcine model.
Source: www.medicalnewstoday.com
# posted by Network @ 3:00 AM
